SOURCE: Brighton Markets

December 01, 2011 09:00 ET

Direction of Market Influences - Report Highlights Gilead Sciences, Inc. and Bristol Myers Squibb Co.

NEW YORK, NY--(Marketwire - Dec 1, 2011) - Today, www.BrightonMarkets.com announced new reports highlighting Gilead Sciences, Inc. (NASDAQ: GILD) and Bristol Myers Squibb Co. (NYSE: BMY). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=GILD&cob=BMY.

Upcoming macro-economic 'tides of influence' are buoyed by crisis both home and abroad. Spanish and Italian yields continue to climb as efforts by the European Central Bank have stopped short of establishing sovereign bond guarantees for any one country. The result is historic yields and a grave concern for the solvency of interbank lending. Markets were drawn to concerns over domestic policy stalemates producing downgrade risks. Despite the situation, there continues to be unique value and opportunity found within careful discretion.

Brighton Markets is releasing new coverage on Gilead Sciences, Inc. for its current position within the healthcare industry. Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases. The Company has operations in North America, Europe and Asia Pacific. The Company's products include Truvada, Atripla, Viread, Emtriva, Hepsera, AmBisome, Letairis, Ranexa, Vistide and Cayston. The full research report on Gilead Sciences, Inc. (NASDAQ: GILD) is available here: www.BrightonMarkets.com/index.php?coa=GILD.

Brighton Markets has released research on Bristol Myers Squibb Co. for its changing role within the healthcare industry. Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The full research report on Bristol Myers Squibb Co. (NYSE: BMY) is available here: www.BrightonMarkets.com/index.php?cob=BMY.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information